a public good project by the
Synthesis
Company
of California

© 2026

Alfredo Rodríguez Antigüedad | doi.page

0 works0 citations0 h-index

Alfredo Rodríguez Antigüedad

BioCruces Health research Institute(ES)Hospital de Cruces(ES)

Publications by Year

Research Areas

Multiple Sclerosis Research Studies, Systemic Sclerosis and Related Diseases, Peripheral Neuropathies and Disorders, Systemic Lupus Erythematosus Research, Cytokine Signaling Pathways and Interactions

Most-Cited Works

→ Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study(2018)906 cited
→ P2X₇Receptor Blockade Prevents ATP Excitotoxicity in Oligodendrocytes and Ameliorates Experimental Autoimmune Encephalomyelitis(2007)398 cited
→ Excitotoxic damage to white matter(2007)254 cited
→ Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial(2019)177 cited
→ Neuromyelitis optica spectrum disorders(2016)151 cited
→ Increased expression of cystine/glutamate antiporter in multiple sclerosis(2011)111 cited

→ FTY720 attenuates excitotoxicity and neuroinflammation(2015)

101 cited

→ The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosis(2010)95 cited

→ Exome sequencing in multiple sclerosis families identifies 12 candidate genes and nominates biological pathways for the genesis of disease(2019)80 cited

→ Gain-of-function of P2X7 receptor gene variants in multiple sclerosis(2011)78 cited